|
|
|
|
|
|
Memory Pharmaceuticals Corp. 100 Philips Parkway Montvale, New Jersey 07645
Phone: (201) 802-7100 Fax: (201) 802-7190
www.memorypharma.com
|
|
|
|
|
May 3, 2005
Mr. James R.
Sulat
Dear Jim:
We are
pleased to inform you that both the Board of Directors (the
“Board”) and management team of Memory Pharmaceuticals
Corp. (the “Company”) are impressed with your
experience and accomplishments, and would like to extend an offer
to you to join the Company as President and Chief Executive
Officer. We look forward to you joining our team, and are confident
that you will contribute significantly to the value of our
organization. We are therefore pleased to provide you with the
terms of your anticipated employment by the Company.
1. Position . Your position will be
President and Chief Executive Officer, based out of the
Company’s offices currently located in Montvale, New Jersey,
and will report directly to the Company’s Chairman and the
Board. You will be elected to the Board as soon as reasonably
practicable following your Start Date (as defined
below).
As a
full-time employee of the Company, you will be expected to devote
your full business time and energies to the business and affairs of
the Company. You agree not to engage in any activities outside of
the scope of your employment that would detract from, or interfere
with, the fulfillment of your responsibilities or duties under this
letter agreement. You agree that you will not serve as a director
or the equivalent position of any company or entity, and will not
render services of a business, professional or commercial nature to
any other person or firm, except for not-for-profit entities,
without the prior written consent of the Board.
Your
performance will be reviewed formally after six (6) months of
employment and annually thereafter at the end of each calendar
year. You acknowledge that a performance review does not guarantee
a salary increase.
2. Starting Date/ Nature of
Relationship . It is expected that your employment will start
on May 6, 2005 or such other date as we may mutually agree
(the “Start Date”). No provision of this letter
agreement shall be construed to create an express or implied
employment contract for a specific period of time. Either you or
the Company may terminate the employment relationship at any time
and for any reason, by giving at least thirty (30) days’
prior written notice to the other party. The Company in its sole
discretion may elect to terminate your employment immediately or
during such thirty (30) day notice period, but in this event
you will continue to receive an amount equal to your base salary,
less applicable deductions, that you otherwise would have received
during the balance of such thirty (30) day notice
period.
3.
Compensation .
(a) Your initial base salary will be at the
bi-weekly rate of $15,192.31, less applicable deductions
(annualized at $395,000).
(b) Effective as of the Start Date, you
will receive stock options to purchase 500,000 shares of the
Company’s Common Stock, which will be in the form of
incentive stock options, to the extent permissible under applicable
law, and the balance will be in the form of non-qualified stock
options. Such stock options (i) will entitle you to purchase
the Company’s Common Stock at the closing price per share of
the Company’s Common Stock on the NASDAQ on the option grant
date, as determined by the Board, in accordance with the
Company’s 2004 Stock Incentive Plan, as amended from time to
time (the “Incentive Plan”) and (ii) shall vest in
quarterly increments over a period of four (4) years as
described in the standard form of Stock Option Agreement, which you
agree to execute and deliver to the Company on or before the Start
Date.
(c) You will also be entitled to a
subsequent grant of stock options not later than January 31,
2006, which will be in the form of incentive stock options to the
extent permissible under applicable law, and the balance will be in
the form of non-qualified stock options. Such stock options
(i) will entitle you to purchase the Company’s Common
Stock at the closing price per share of the Company’s Common
Stock on the NASDAQ on the option grant date, as determined by the
Board, in accordance with the Incentive Plan and (ii) shall
vest in quarterly increments over a period of four (4) years
as described in the standard form of Stock Option Agreement, which
you agree to execute and deliver to the Company on or before the
option grant date. Such subsequent grant of stock options shall be
made as follows:
(i) if, at the Company’s 2005 Annual
Meeting, shareholders of the Company approve (x) an increase
in the number of shares of the Company’s Common Stock
available for options to be granted under the Incentive Plan and
(y) a waiver of Section 4.1(d) of the Incentive Plan
(collectively, the “Incentive Plan Proposal”), then you
will receive stock options to purchase 525,000 shares of the
Company’s Common Stock (the “Subsequent Grant”),
which shares shall be granted on the next day following
registration with the SEC of the shares of the Common Stock
underlying the Subsequent Grant; or
(ii) if, the shareholders of the Company do
not approve the Incentive Plan Proposal, then you will receive
stock options to purchase 500,000 shares of the Company’s
Common Stock (the “Reduced Subsequent Grant”), which
shares shall be granted on the next day following registration with
the SEC of the shares of the Common Stock underlying the Reduced
Subsequent Grant, which shall occur no later than January 31,
2006.
(d) You will be eligible to receive an
annual bonus dependent on the performance of the Company and your
individual performance, subject to the discretion of the Board.
Your target bonus will be equal to thirty-five percent (35%) of
your base salary, assuming the achievement of such Company and
individual performance objectives. The actual amount paid, if any,
shall be determined by the Board in its sole discretion.
(e) Upon termination of your employment for
any reason, the Company will pay you, within two (2) weeks of
such termination, your current base salary earned through the
termination date, plus accrued vacation, if any, and other benefits
or payments, if any, to which you are entitled. In the event your
employment is terminated by the Company without “Cause”
(as defined below) or by you for “Good Reason” (as
defined below), then the Company will continue for a period of
twelve (12) months to (i) pay you your bi-weekly rate in
effect at the time of termination, less applicable deductions,
(ii) provide and pay the Company’s portion of your
medical and dental insurance, and (iii) pay you in monthly
installments one-twelfth (1/12) of your average annual bonuses for
the previous three (3) calendar years (or such shorter period if
you have not been employed for three (3) calendar years). In
addition, if your employment is terminated by the Company without
Cause or by you for Good Reason (other than the termination of your
employment as described in the immediately succeeding sentence),
you will be entitled to accelerated vesting of twenty-five percent
(25%) of your unvested stock options as of the date of such
termination of your employment. If within three (3) months
prior to, or within eighteen (18) months after, the occurrence
of a Change of Control (as defined below), your employment is
either terminated by the Company without Cause or you terminate
your employment with the Company upon the occurrence of any of the
events described in Section 3(g) (ii) – (v) below, your
unvested stock options will become fully vested. Upon the
occurrence of the accelerated vesting of your stock options as
described in the preceding two (2) sentences, (i) with
respect to your incentive stock options, such options must be
exercised by you within ninety (90) days after the termination
of your employment and (ii) with respect to your non-qualified
stock options, such options must be exercised by you on or before
the date that is the later to occur of (i) ninety
(90) days after the date of termination of your employment or
(ii) January 15 th of the calendar year immediately
succeeding the date of termination of your employment. The Company
will not be obligated to continue any such payments to you or
accelerate vesting of your stock options under this paragraph 3(e)
in the event you materially breach the terms of this letter
agreement or the Confidentiality Agreement (as defined below).
Notwithstanding any termination of your employment for any reason
(with or without Cause or for Good Reason), you will continue to be
bound by the provisions of the Confidentiality
Agreement.
All payments and benefits provided pursuant to
this paragraph 3(e) shall be conditioned upon your execution and
non-revocation of a general release substantially in the form
attached hereto as Exhibit A at the time of
termination. Your refusal to execute a general release shall
constitute a waiver by you of any and all benefits referenced in
this paragraph 3(e). The Company will not be obligated to continue
any such payments to you under this paragraph 3(e) in the event you
materially breach the terms of this letter agreement or the
Confidentiality Agreement.
(f) For the purposes of this paragraph 3,
“Cause” shall include (i) your conviction of a
felony, either in connection with the performance of your
obligations to the Company or otherwise, which adversely affects
your ability to perform such obligations or materially adversely
affects the business activities, reputation, goodwill or image of
the Company, (ii) your willful disloyalty, deliberate
dishonesty, breach of fiduciary duty, (iii) your breach of the
terms of this letter agreement, or your failure or refusal to carry
out any material tasks or responsibilities assigned to you by the
Company in accordance with the terms hereof, which breach or
failure continues for a period of more than thirty (30) days
after your receipt of written notice thereof from the Company,
(iv) the commission by you of any act of fraud, embezzlement
or deliberate disregard of a significant rule or policy of the
Company known to you or contained in a policy and procedure manual
provided to you which results in material loss, damage or injury to
the Company, or (v) the material breach by you of any of the
provisions of the Confidentiality Agreement.
(g) For the purpose of this paragraph 3,
the termination of your employment for “Good Reason”
shall mean the termination by you of your employment with the
Company (i) within eighteen (18) months after a
“Change in Control” (as defined below) or the sale of a
majority of the assets, obligations, or business of the Company
(whether by merger, sale of stock or otherwise), (ii) within
three (3) months after a material diminution in your
responsibilities (provided that such diminution is not in
connection with the termination of your employment for Cause),
(iii) within three (3) months after you no longer report
to the Board or cease to be a member of the Board (other than as a
result of any act or circumstance relating to your inability,
failure or refusal to serve as a member of the Board),
(iv) within three (3) months of your principal work
location changing to be more than fifty (50) miles from the
Company’s principal offices or (v) within three
(3) months after the reduction by the Company of the amount of
your base salary, unless such reduction is pursuant to a plan and
as a consequence the base salaries of the Company’s
executives are reduced generally. The Company shall notify you,
within sixty (60) days of receipt of your notice of intent to
terminate your employment for Good Reason if the Company disagrees
with your intent to terminate under this paragraph. For the
purposes of this letter agreement, “Change of Control”
shall be deemed to have occurred if the Company is consolidated
with or acquired by another entity in a merger, sale of all or
substantially all of the Company’s assets or shares of stock
or otherwise (excluding (A) transactions solely for the
purpose of reincorporating the Company in a different jurisdiction
or recapitalizing or reclassifying the Company’s stock, or
(B) any merger or consolidation in which the shareholders of
the Company immediately prior to such merger or consolidation
continue to own at least a majority of the outstanding voting
securities of the Company or the surviving entity after such merger
of consolidation).
4. Benefits . You will be entitled
as an employee of the Company to receive such benefits as are
generally provided its employees and executives and for which you
are eligible in accordance with Company policy as in effect from
time to time. The Company retains the right to change, add or cease
any particular benefit relating to its employees and executives
generally. At this time, the Company is offering a benefit program,
consisting of medical, dental, life and short/long term disability
insurance, as well as a 401(k) retirement plan and flexible
spending plan. You will be eligible for eleven (11) paid
holidays, four (4) floating holidays and four (4) weeks paid
vacation per year, which will be pro-rated for the 2005 calendar
year based on the Start Date. You will accrue additional vacation
days in accordance with Company policy.
5. Indemnification . The Company
will indemnify you in connection with any legal proceedings related
thereto, including after your employment with the
Company.
6. Confidentiality . The Company
considers the protection of its confidential information and
proprietary materials to be very important. Therefore, as a
condition of your employment, you will be required to execute and
deliver to the Company, on or before the Start Date, the
Confidentiality and Noncompetition Agreement substantially in the
form of Exhibit B attached hereto (the
“Confidentiality Agreement”).
7.
General .
(a) This letter agreement, together with
the Confidentiality Agreement and the Stock Option Agreement, will
constitute our entire agreement as to your employment by the
Company and will supersede any prior agreements or understandings,
whether in writing or oral.
(b) This letter agreement shall be subject
to and contingent upon the satisfactory results of the
Company’s due diligence, such as a medical examination,
satisfactory reference, background and education
verification.
(c) This letter agreement and the
Company’s obligations hereunder shall be subject to review
and approval by the Board and the Compensation Committee
thereof.
(d) This letter agreement shall be governed
by the law of the State of New Jersey. In the event of any legal
proceedings relating to this letter agreement and/or the subject
matter thereof, the parties consent to the exclusive jurisdiction
of the courts located in the State of New Jersey. THE PARTIES
HEREBY EXPRESSLY WAIVE THEIR RIGHT TO HAVE A JURY TRIAL.
You
may accept this offer of employment and the terms thereof by
signing the enclosed additional copy of this letter agreement and
the Confidentiality Agreement and the Stock Option Agreement, which
execution will evidence your agreement with the terms set forth
herein and therein, and returning them to the Company.
This
offer of employment will expire on May 5, 2005, unless
accepted by you prior to such date. We look forward to you joining
our team, and we believe that your skills will compliment those of
our existing management team, and that you will make a significant
contribution to Memory’s growth. We look forward to your
prompt response to this offer letter.
Sincerely,
MEMORY PHARMACEUTICALS CORP.
|
|
|
|
|
|
|
|
|
|
|
|
Name:Tony
Scullion
Title: President and Chief Executive Officer
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Date: May 3, 2005
1
EXHIBIT A
FORM OF GENERAL RELEASE OF
CLAIMS
GENERAL RELEASE OF CLAIMS
For
and in consideration of the payments and other benefits described
in the letter agreement dated as of May 3 2005 (the “Letter
Agreement”) by and between Memory Pharmaceuticals Corp. (the
“Company”), and James R. Sulat (“Employee”)
and for other good and valuable consideration, Employee hereby
releases the Company and its respective divisions, operating
companies, affiliates, subsidiaries, parents, branches,
predecessors, successors, assigns, officers, directors, trustees,
employees, agents, shareholders, administrators, representatives,
attorneys, insurers and fiduciaries, past, present and future (the
“Released Parties”), from any and all claims of any
kind arising out of or related to Employee’s employment with
the Company, Employee’s separation from employment with the
Company or derivative of Employee’s employment, which
Employee now has or may have against the Released Parties, whether
known or unknown to Employee, by reason of facts which have
occurred on or prior to the date that Employee has signed this
General Release of Claims. Such released claims include, without
limitation, any alleged violation of the Age Discrimination in
Employment Act, as amended, the Older Worker Benefits Protection
Act; Title VII of the Civil Rights of 1964, as amended;
Sections 1981 through 1988 of Title 42 of the United States
Code; the Civil Rights Act of 1991; the Equal Pay Act; the
Americans with Disabilities Act; the Rehabilitation Act; the Family
and Medical Leave Act; the Fair Labor Standards Act; the Employee
Retirement Income Security Act of 1974, as amended; the Worker
Adjustment and Retraining Notification Act; the National Labor
Relations Act; the Fair Credit Reporting Act; the Occupational
Safety and Health Act; the Uniformed Services Employment and
Reemployment Act; the Employee Polygraph Protection Act; the
Immigration Reform Control Act; the retaliation provisi